수두증 션트 시장 보고서 : 유형별, 제품 유형별, 연령층별, 최종사용자별, 지역별(2025-2033년)
Hydrocephalus Shunts Market Report by Type, Product Type, Age Group, End User, and Region 2025-2033
상품코드:1722611
리서치사:IMARC
발행일:2025년 05월
페이지 정보:영문 140 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
수두증 션트 세계 시장 규모는 2024년에 4억 6,720만 달러에 달했습니다. 향후 IMARC Group은 2033년까지 6억 4,210만 달러에 달할 것으로 예상하며, 2025년부터 2033년까지 3.42%의 연평균 성장률(CAGR)을 기록할 것으로 예측하고 있습니다. 이 시장은 주로 수두증 발병률 증가, 헬스케어의 발전, 션트 설계의 기술 혁신에 의해 주도되고 있습니다. 또한, 선천성 수두증 환자의 증가와 소아 인구의 급속한 증가는 시장 성장을 크게 촉진하고 있습니다.
수두증 션트 시장 분석:
주요 시장 촉진요인 : 수두증 션트 시장 규모는 의료 인프라의 발전, 수두증 유병률 증가, 션트 개발의 기술 발전에 의해 주도되고 있습니다. 이에 따라 노인 인구와 소아 인구의 증가는 시장 확대에 크게 기여하고 있습니다. 또한, 유리한 상환 정책과 조기 치료 및 발견 방법에 대한 인식이 높아지면서 시장 성장을 더욱 촉진하고 있습니다. 또한, 수두증을 포함한 신경 퇴행성 질환에 대한 연구에 많은 투자가 이루어지고 효과적인 션트 솔루션의 기술 혁신과 제조가 촉진되고 있는 것도 시장 규모 확대에 매우 중요한 역할을 하고 있습니다.
주요 시장 동향 : 수두증 션트 시장의 주요 동향으로는 환자 예후 개선에 박차를 가하는 안티 사이펀, 프로그래머블 션트와 같은 첨단 기술의 급속한 통합이 있습니다. 신흥국에서는 의료비 지출과 인프라 확충으로 인해 수요가 확대되고 있습니다. 또한, 소아 수두증 환자의 급증도 특수 션트에 대한 수요를 촉진하고 있습니다. 또한, 연구개발에 대한 막대한 투자가 혁신적인 제품 설계를 창출하는 원동력이 되고 있습니다. 동시에, 인식의 증가와 진단율의 향상으로 신속한 개입이 필요한 사례를 식별함으로써 시장 성장에 박차를 가하고 있습니다.
지리적 동향 : 북미는 우수한 의료 시스템과 함께 수두증 사례가 증가함에 따라 세계 수두증 시장 분석에서 견고한 성장세를 보이고 있습니다. 미국은 솔루션의 연구개발과 혁신적인 의료기기의 보급을 주도하고 있습니다. 유리한 상환 프로토콜과 강력한 전문 의료 서비스 제공자 네트워크가 이 시장을 더욱 촉진하고 있으며, 북미는 세계 수두증 션트 시장에서 지배적인 지역이 되었습니다.
도전과 기회 : 세계 뇌수막염 시장 개요에 나타난 주요 도전과제로는 필요한 기술 발전, 재수술률 증가, 심각한 합병증 등이 있습니다. 그러나 이러한 도전과제는 재수술률이 낮은 생체적합성 및 프로그램 가능한 션트 제조와 같은 기술 혁신의 기회를 제공하고 있습니다. 수두증에 대한 진단과 인식이 개선되고, 신흥국에서의 헬스케어 보급은 더 큰 성장 기회를 창출하고 있습니다. 또한, 연구 기관과 조직의 자금 조달은 경쟁력을 높이고 환자 치료 결과를 개선할 수 있습니다.
수두증 션트 시장 동향:
선천성 질환과 소아 인구 증가
수두증 션트 세계 시장 점유율에서 중요한 추세는 영유아와 소아에서 선천성 수두증의 유병률 증가입니다. The World Counts에 따르면 매일 385,000명, 즉 연간 1억 4,000만 명의 아기가 태어나고 있으며, 이는 시장 역학에서 매우 중요한 역할을 합니다. 선천성 질환의 증가는 소아 션트 솔루션에 대한 수요를 증가시키고 있습니다. 존 홉킨스 병원에 따르면, 미국에서는 1,000명 중 1-2명이 선천성 수두증을 앓고 있다고 합니다. 이에 따라 제조업체들은 현재 이 연령대 특유의 생리적, 해부학적 요구를 고려하여 소아 및 유아 전용 션트 설계에 주력하고 있습니다.
첨단 기술의 신속한 채택
세계 뇌수막염 션트 시장은 사이펀 방지 션트 및 프로그래밍 가능한 션트와 같은 첨단 기술의 채택이 급증하고 있는 현저한 추세를 목격하고 있습니다. Journal of Neurosurgery 저널에 게재된 연구 논문에 따르면, 프로그램 가능한 션트는 뇌척수액 흐름을 정확하게 조절하여 환자의 예후를 개선하며, 뇌수두증 치료에서 프로그램 가능한 션트가 프로그램 불가능한 션트보다 재수술률이 낮다는 연구 결과가 발표되었습니다. 그 결과, 프로그램 가능한 션트가 더 비용 효율적임이 입증되었습니다. 연구에 따르면, 프로그램 가능한 션트를 사용한 환자의 7%가 재수술이 필요한 반면, 프로그램 불가능한 션트를 사용한 환자의 21.6%가 재수술이 필요한 것으로 나타났습니다. 또한, 원격 모니터링 및 원격의료 시스템 도입으로 수술 후 관리가 향상되고 잦은 병원 방문의 필요성이 줄어들어 더욱 보급이 확대되고 있습니다.
신흥국의 제품 보급률 증가
수두증 세계 시장 점유율은 주로 의료 지출 증가와 의료 인프라 강화로 인해 신흥국 시장에서 밝은 전망을 보이고 있습니다. 중국과 인도와 같은 국가에서는 환자 인식이 높아지고 의료 시설이 개선됨에 따라 수두증 션트 보급률이 증가하고 있습니다. 업계 보고서에 따르면, 아시아태평양은 2024년 견조한 경제 성장을 보일 것으로 예상되며, 인도의 GDP는 5%로 성장할 것으로 추정됩니다. 시장 확대는 의료 시설을 강화하려는 정부의 노력과 미충족 의료 수요를 충족시키는 것을 목표로 하는 이들 경제권에서 대기업의 입지를 강화함으로써 더욱 촉진될 것입니다.
The global hydrocephalus shunts market size reached USD 467.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 642.1 Million by 2033, exhibiting a growth rate (CAGR) of 3.42% during 2025-2033. The market is primarily driven by the rising incidence of hydrocephalus, advanced healthcare infrastructure, and technological innovations in shunts design. Moreover, increasing cases of congenital hydrocephalus and rapid proliferation of pediatric population are significantly driving the market growth.
Hydrocephalus Shunts Market Analysis:
Major Market Drivers: The hydrocephalus shunts market size is driven by advancing healthcare infrastructure, escalating prevalence of hydrocephalus, and technological advancements in shunt development. In line with this, the growing geriatric and pediatric populations are substantially aiding the market toward expansion. Additionally, preferable money repayment policies and surge in awareness about early treatment and detection methods further spur market growth. Heavy investments in research of neurogenerative diseases, including hydrocephalus, prompting innovations and manufacturing of effective shunt solutions, also play a pivotal role in expanding the hydrocephalus shunts market size.
Key Market Trends: Some of the major hydrocephalus shunts market trends involve rapid integration of cutting-edge technology, including anti-siphon and programmable shunts, spurred by their improved patient outcomes. There is an escalating demand in emerging economies primarily due to enhancing healthcare expenditure and infrastructure. Surge in pediatric hydrocephalus incidents is also propelling the demand for specialized shunts. Moreover, substantial investments in R&D are driving the creation of innovative product designs. Concurrently, heightened awareness and improved diagnostic rates are fueling the market growth by identifying cases that require prompt intervention.
Geographical Trends: North America is depicting a robust growth in the global hydrocephalus market analysis due to the rising cases of hydrocephalus in the region, coupled with superior healthcare systems. The United Sates leads in the research and development of hydrocephalus shunts solutions and the widespread adoption of innovative medical equipment. Advantageous reimbursement protocols and a strong network of professional healthcare providers further boost this market, establishing North America as a dominant region in the global hydrocephalus shunt market.
Competitive Landscape: Some of the major market players in the hydrocephalus industry include Argi Group, B. Braun Melsungen AG, Christoph Miethke GmbH & Co. KG, G. Surgiwear Ltd., HLL Lifecare Limited, Integra LifeSciences, Kaneka Medix Corporation (Kaneka Corporation), Medtronic Plc, Natus Medical Incorporated, Sophysa, Spiegelberg GmbH & Co. KG (SHS Medizintechnik Holding GmbH), and TKB Corporation, among many others.
Challenges and Opportunities: The prime challenges witnessed in the global hydrocephalus market overview include requisite technological advancements, increased revision rates, and critical complications. Nonetheless, such challenges offer opportunities for innovations, especially in manufacturing biocompatible and programmable shunts that have lower revision rates. The increasing diagnosis and awareness of hydrocephalus, together with proliferating healthcare infrastructure in emerging countries, further generate substantial growth opportunities. Moreover, funding in research institutes and organizations can enhance competitiveness and positive patient outcomes.
Hydrocephalus Shunts Market Trends:
Increasing Congenital Cases and Pediatric Population
A significant trend in the global hydrocephalus shunts market share is the increasing prevalence of congenital hydrocephalus among infants and children. In addition, rapid growth in pediatric population is also playing a pivotal role in market dynamics. According to The World Counts, each day 385,000 babies are born, i.e., 140 million a year. The heightening incidents of congenital cases has boosted the demand for pediatric shunt solutions. According to John Hopkins Hospital, 1 or 2 of every 1000 infants born in U.S. have congenital hydrocephalus. As a result, manufacturers are currently emphasizing on designing specialized shunts for children and infants, acknowledging the distinct physiological and anatomical needs of this age group.
Rapid Adoption of Advanced Technologies
The global hydrocephalus shunts market is witnessing a notable trend towards the escalating adoption of advanced technologies, including anti-siphon and programmable shunts. Such innovations improve patient outcomes by permitting accurate adjustments of cerebrospinal fluid flow. According to a research article published in the Journal of Neurosurgery, programmable shunts depict lower revision rates than nonprogrammable shunts for the treatment of hydrocephalus. Consequently, programmable shunts are proven to be more cost-efficient. The research showed that 7% of patients with programmable shunts needed revisions, while 21.6% of patients with nonprogrammable shunts required revisions. Additionally, the incorporation of remote monitoring and telehealth systems is further driving adoption by improving post-operative care and lowering the need for frequent hospital visits.
Increasing Product Prevalence in Emerging Economies
The global hydrocephalus market share is witnessing a positive outlook in emerging market principally due to increase in healthcare spending and enhanced healthcare infrastructure. Countries like China and India are undergoing elevated adoption rates of hydrocephalus shunts primarily because of heightening patient awareness and improved medical facilities. As per industry reports, Asia Pacific is projected to depict a robust economic growth in 2024 with India's GDP estimated to grow by 5%. The market expansion is further propelled by government initiatives to enhance healthcare facilities and the strengthening presence of major companies in these economies, targeting to address the unmet medical demands.
Hydrocephalus Shunts Market Segmentation:
Breakup by Type:
Ventriculo-Peritoneal
Ventriculo-Atrial
Ventriculo-Pleural
Lumbo-Peritoneal
Ventriculo-peritoneal accounts for the majority of the market share
The ventriculo-peritoneal (VP) represents the majority of the global hydrocephalus shunts market share as it is reliable, highly effective, and is largely accepted in clinical applications. VP shunts demonstrate high success rates in patients with hydrocephalus, aiding in strengthening its dominance in the market dynamics. The widespread utilization of VP shunts in adults as well as pediatrics further facilitate their market growth. As per a clinical report, approximately 750,000 individuals are diagnosed with hydrocephalus, while 160,000 VP shunts are implanted each year globally. Moreover, the robust support from medical professionals and advantageous healthcare policies assists in sustaining hydrocephalus shunts market share and growth.
Breakup by Product Type:
Hydrocephalus Valves
Adjustable Pressure Valves
Fix Pressure Valves
Hydrocephalus Catheters
Hydrocephalus valves hold the largest share of the industry
Hydrocephalus valves play a critical role in regulating the flow of cerebrospinal fluid. Valves are integral component of hydrocephalus shunt system as they aid in maintaining intracranial pressure. Adjustable pressure valves have flexible built, designed to address pressure settings as per the patient needs. Fixed pressure valves are comparatively less versatile but are cost-efficient and reliable. Advancements in manufacturing technology of valves and innovations further strengthen the segment's growth in the global hydrocephalus shunts market share. For instance, Integra LifeSciences has innovated the valves design by manufacturing various variants of fixed pressure valves, including Ultra VS valves, Pudenz Valves, Mishler On/Off valves, and CODMAN HAKIM Precision Fixed Pressure Valves.
Breakup by Age Group:
Infants
Children
Adults
Children represent the leading market segment
Children hold the largest segment in the global hydrocephalus shunts market share due to an elevated prevalence of congenital hydrocephalus and the intense demand for early detection and treatment. According to the National Institutes of Health, it is estimated that each year approximately 400,000 new cases of pediatric hydrocephalus will develop globally. Furthermore, according to a research article published in the Journal of Neurosurgey, Asia also depicts prevalence of pediatric hydrocephalus. In the study, 29% of nonpostinfectious hydrocephalus and 10.7% of postinfectious hydrocephalus were identified across Asia. Specialized shunt systems and development in pediatric neurosurgery for children plays a pivotal role in hydrocephalus shunts market dynamics. Additionally, intensifying awareness about neurogenerative diseases in children and enhanced diagnostics techniques facilitates the segment dominance.
Breakup by End User:
Hospitals
Ambulatory Surgical Centers
Hospitals exhibit a clear dominance in the market
Hospitals hold the largest segment as an end user in the global hydrocephalus shunts market forecast because of their superior medical infrastructure, ability to execute critical surgeries, and competent healthcare professionals. Hospitals greatly profit from elevated patient inflow, particularly for critical hydrocephalus cases that demand specialized treatments. According to Hydrocephalus Association, pediatric hydrocephalus accounts for over 40,000 hospital admissions annually, with nearly 10,000 of these admissions resulting from shunt malfunctions. Moreover, facilities like thorough post-surgical care and advanced technologies also fortifies their position in the hydrocephalus shunt market dynamics. Additionally, strategic partnerships between manufacturers and hospitals facilitates a reliable supply chain, improving latter's pivotal role in this market share.
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America leads the market, accounting for the largest hydrocephalus shunts market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for hydrocephalus shunts.
North America is the dominant region in the global hydrocephalus shunts market share primarily due to increasing prevalence of hydrocephalus and cutting-edge healthcare infrastructure. According to USF Health, more than 800,000 Americans are suffering with hydrocephalus, while 1%-5% patients that are suffering with dementia are estimated to have hydrocephalus. The region, particularly United States, is leading in research and development sector and extensive utilization of advanced medical technologies. For instance, Indiana University (IU) in Indianapolis was granted with USD 243 million research fund from the National Institutes of Health in 2023. IU is growing rapidly in R&D and has established Hydrocephalus Research Center that aims to discover hydrocephalus solutions. Canada also has a substantial contribution in the regional market dynamics due to rising patient awareness and robust healthcare policies in the country. This regional domination is also strengthened by preferable pay back policies and an entrenched healthcare providers network.
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the hydrocephalus shunts industry include Argi Group, B. Braun Melsungen AG, Christoph Miethke GmbH & Co. KG, G. Surgiwear Ltd., HLL Lifecare Limited, Integra LifeSciences, Kaneka Medix Corporation (Kaneka Corporation), Medtronic Plc, Natus Medical Incorporated, Sophysa, Spiegelberg GmbH & Co. KG (SHS Medizintechnik Holding GmbH) and TKB Corporation.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
The global hydrocephalus shunts market outlook is represented by an intense competition due to the presence of key companies that are dominating the market share through broad product portfolios, innovative technologies, and strategic acquisitions and partnerships. For instance, in July 2023, CereVasc formed a strategic partnership with LianMedical, a China-based medical device company, to release its eShunt system and other related products to providers and patients in East Asian countries China, Hong Kong, Taiwan, and Macaw. Emerging companies are establishing their positions by emphasizing on cost-efficient product formulations and advancements in technology. Regional competitors also contribute substantially, utilizing regulatory policies and local market expertise. Robust research and development, coupled with continuous striving to improve patient outcomes, further fuel the competition and contribute to market evolution.
Key Questions Answered in This Report
1.What was the size of the global hydrocephalus shunts market in 2024?
2.What is the expected growth rate of the global hydrocephalus shunts market during 2025-2033?
3.What has been the impact of COVID-19 on the global hydrocephalus shunts market?
4.What are the key factors driving the global hydrocephalus shunts market?
5.What is the breakup of the global hydrocephalus shunts market based on the type?
6.What is the breakup of the global hydrocephalus shunts market based on the product type?
7.What is the breakup of the global hydrocephalus shunts market based on the age group?
8.What is the breakup of the global hydrocephalus shunts market based on the end user?
9.What are the key regions in the global hydrocephalus shunts market?
10.Who are the key players/companies in the global hydrocephalus shunts market?
